>_ QFI Terminal
Terminal › Stocks › CDT

CDT Equity Inc. (CDT) Stock

Healthcare · Biotechnology · US
$0.48 -13.90%
Last updated Nov 12, 2026 09:30 UTC

CDT Key Statistics

Market Cap$85,466.29
P/E (TTM)0.00
P/S (TTM)0.00
P/B (TTM)0.00
Revenue (TTM)$2.72B
EPS (TTM)$1,477.50
Dividend Yield—
ROE (TTM)74.52%
Net Margin8.75%
Gross Margin37.98%
52W High$85.00
52W Low$0.30
Analyst View—
Price Target—
Employees6
Volume179,707

About CDT Equity Inc.

CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.

CEO: Andrew Regan. Company website

CDT — Frequently Asked Questions

What is the CDT stock price today?

CDT Equity Inc. (CDT) trades at $0.48, down 13.90% on the day, as of Nov 12, 2026 09:30 UTC.

What is CDT Equity Inc.'s market cap?

CDT Equity Inc. has a market capitalisation of $85,466.29, calculated from the live CDT share price and shares outstanding.

What is the P/E ratio of CDT?

CDT trades at a trailing P/E of 0.00, from earnings per share of $1,477.50 over the last twelve months.

How much revenue does CDT Equity Inc. make?

CDT Equity Inc. generated revenue of $2.72B over the trailing twelve months, which puts the stock at 0.00 times sales.

What is the 52-week range for CDT?

CDT has traded between $0.30 and $85.00 over the past 52 weeks, and the last price is 99.4% below that high.

Is CDT Equity Inc. profitable?

Yes. CDT Equity Inc. keeps 8.75% of revenue as net income over the trailing twelve months.

What sector is CDT Equity Inc. in?

CDT Equity Inc. is classified under the Healthcare sector and the Biotechnology industry, and is domiciled in US .

Who is the CEO of CDT Equity Inc.?

Andrew Regan is the chief executive of CDT Equity Inc., which employs 6 people.

Where can I track CDT in real time?

QFI Terminal shows CDT with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See CDT live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open CDT in Terminal See plans

Biotechnology stocks

REGN Regeneron Pharmaceuticals, Inc. VRTX Vertex Pharmaceuticals Incorporated ONC BeOne Medicines AG INCY Incyte Corporation ALNY Alnylam Pharmaceuticals, Inc. JAZZ Jazz Pharmaceuticals plc ARGX argenx SE GMAB Genmab A/S NBIX Neurocrine Biosciences, Inc. BMRN BioMarin Pharmaceutical Inc. UTHR United Therapeutics Corporation MRNA Moderna, Inc. EXEL Exelixis, Inc. BNTX BioNTech SE SRPT Sarepta Therapeutics, Inc. HALO Halozyme Therapeutics, Inc. INSM Insmed Incorporated MDGL Madrigal Pharmaceuticals, Inc. TECH Bio-Techne Corporation ASND Ascendis Pharma A/S CAI Caris Life Sciences, Inc. IONS Ionis Pharmaceuticals, Inc. BBIO BridgeBio Pharma, Inc. TGTX TG Therapeutics, Inc.

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. CNC Centene Corp. ELV Elevance Health Inc. HUM Humana Inc. JNJ Johnson & Johnson LLY Eli Lilly and Company HCA HCA Healthcare, Inc. MRK Merck & Co., Inc. ABBV AbbVie Inc. PFE Pfizer Inc.